悦康药业 (688658)
Youcare Pharmaceutical Group Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 45000.00
- Circulating A-Shares(W): 45000.00
- Earnings Per Share(RMB): -0.3300
- Net Assets Per Share(RMB): 7.6214
- Operating Revenue(W RMB): 175910.61
- Total Profit(W RMB): -16481.13
- **Net Profit Attributable to Parent(W RMB) **: -14797.80
- Net Profit Growth Rate(%): -170.56
- Weighted Return on Equity(%): -4.2200
- Operating Cash Flow Per Share(RMB): 0.3740
- Undistributed Profit Per Share(RMB): 0.5368
- Capital Reserve Per Share(RMB): 5.8782
2. Main Business
The main business covers:
- Research, development, production, and sales of high-end chemical drugs
- Full industry chain including drug research and development, manufacturing, distribution, and sales
3. Company Basic Information
- Company Name: Youcare Pharmaceutical Group Co., Ltd.
- Listing Date: 2020-12-24
- Industry: Pharmaceutical Manufacturing
- Address: No. 6 Hongda Middle Road, Beijing Economic-Technological Development Area, Beijing
- Website: https://www.youcareyk.com/
- Company Profile: In April 2019, Youcare Limited convened a shareholders' meeting and passed a resolution to establish Youcare Pharmaceutical Group Co., Ltd. as a joint stock company with 26 shareholders of Youcare Limited as the co-founders. The establishment was based on the net assets audited by Ruihua Certified Public Accountants (Special General Partnership) as of July 31, 2018, which were converted into 360 million shares of the joint stock company, with the remaining balance recorded as capital reserve. In March 2020, Rongcheng Certified Public Accountants reviewed the capital contribution for this overall transformation and issued the "Capital Verification Report" (Rongcheng Yan Zi [2020] 230Z0038). In May 2019, the aforementioned 26 founders signed the "Sponsor Agreement" and convened the founding meeting on the same day, approving the plan to establish the joint stock company through overall transformation. They reviewed and passed the company's articles of association, as well as resolutions regarding the rules of procedure for the shareholders' meeting, board of directors, and board of supervisors, and elected the first board of directors and board of supervisors of Youcare Co., Ltd. In May 2019, Youcare Co., Ltd. obtained the renewed business license from the Beijing Administration for Industry and Commerce Economic-Technological Development Area Branch.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Fuyang Jingyue Yongshun Information Consulting Co., Ltd. | General Legal Person | 15374.01 | 34.16 |
| 2 | Heze Sanrong Equity Investment Partnership (Limited Partnership) | General Legal Person | 1440.00 | 3.20 |
| 3 | Heze Fengsheng Equity Investment Partnership (Limited Partnership) | General Legal Person | 1278.00 | 2.84 |
| 4 | Heze Jinran Equity Investment Partnership (Limited Partnership) | General Legal Person | 1278.00 | 2.84 |
| 5 | Fullgoal Precision Medical Flexible Allocation Mixed Securities Investment Fund - Class A | Fund | 1077.41 | 2.39 |
| 6 | E Fund Health Care Industry Mixed Securities Investment Fund - Class A | Fund | 976.65 | 2.17 |
| 7 | Heze Hewang Equity Investment Partnership (Limited Partnership) | General Legal Person | 720.00 | 1.60 |
| 8 | Fullgoal Pharmaceutical Innovation Equity Securities Investment Fund - Class A | Fund | 683.22 | 1.52 |
| 9 | Fullgoal Tianbo Innovation Theme Mixed Securities Investment Fund | Fund | 632.26 | 1.41 |
| 10 | China Merchants Pharmaceutical Health Industry Equity Securities Investment Fund | Fund | 311.97 | 0.69 |
5. Concept Sectors
- Immunotherapy
- Artificial Intelligence
- Generic Drugs
- Helicobacter Pylori
- Innovative Drugs
- AI Healthcare
- Margin Trading & Securities Lending
- Equity Transfer
- Break Issue Price
- STAR Market Biotech
- STAR 200
- SSE 580
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information